Concord Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Concord Biotech Ltd. on BSE

Load latest

Concord Biotech Ltd.

12 Nov 2024

1582.30

-1.77%

Concord Biotech Results Earnings Call for Q2FY25

Conference Call with Concord Biotech Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.

Concord Biotech Ltd.

12 Nov 2024

1582.30

-1.77%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to regulations 47 of SEBI(LODR) Regulations,2015, please find enclosed herewith extracts of the Unaudited Standalone and Consolidated financial results for the second quarter and half year ended September 30, 2024 as published in the Financial Express Newspaper on 12th November, 2024

pdf

Concord Biotech Ltd.

11 Nov 2024

1582.30

-1.77%

Investor Presentation

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of SEBI(LODR)Regulations, 2015 Investor Presentation on financial results for the second quarter and half year ended 30th September,2024 is enclosed. Kindly take note the records

pdf

Concord Biotech Ltd.

11 Nov 2024

1582.30

-1.77%

Result

Concord Biotech Ltd - 543960 - Unaudited Financial Results For The Second Quarter And Half Year …

BSE India

Pursuant to Regulation 30 and 33 of the SEBI(LODR) regulations, 2015, as amended from time to time, we enclosed herewith the unaudited standalone and consolidated financial statement for the second quarter and half year ended September 2024, along with the limited review report with unmodified opinion issued by M/s. BSR & co. LLP, the statutory auditors.

pdf

Concord Biotech Ltd.

11 Nov 2024

1582.30

-1.77%

Board Meeting

Concord Biotech Ltd - 543960 - Board Meeting Outcome for Outcome Of Board Meeting Held Today, …

BSE India

Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company for the Second quarter and half year ended September 30, 2024, along with the Limited Review Report with Unmodified Opinion issued by M/s. BSR & Co. LLP, the Statutory auditors.

pdf

Concord Biotech Ltd.

06 Nov 2024

1582.30

-1.77%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Revised Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended 30 September, 2024, scheduled on Tuesday, 12th November, 2024 at 2:00 P.M. IST

pdf

Concord Biotech Ltd.

06 Nov 2024

1582.30

-1.77%

Company Update

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Earnings Call with Investor/Analyst (Participants) to discuss the Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended 30 September, 2024, scheduled on Tuesday, 12th November, 2024 at 03:30 P.M. IST

pdf

Concord Biotech Ltd.

06 Nov 2024

1582.30

-1.77%

Board Meeting

Concord Biotech Ltd - 543960 - Board Meeting Intimation for Board Meeting Intimation For Approve The …

BSE India

Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2024 ,inter alia, to consider and approve The Standalone and Consolidated Unaudited Financial Results for the Second quarter and half year ended September 30, 2024, along with limited review report to be issued by the Statutory Auditors and to consider other business matters, if any

pdf

Concord Biotech Ltd.

10 Oct 2024

1582.30

-1.77%

Company Update

Concord Biotech Ltd - 543960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP)Regulation, 2018 for the quarter ended 30.09.2024.

pdf

Concord Biotech Ltd.

25 Sep 2024

1582.30

-1.77%

SAST

Concord Biotech Ltd - 543960 - Closure of Trading Window

BSE India

The trading window for dealing in the securities of the Company will be closed for all designated persons and their immediate relatives with effect from 1st October 2024 and the same will remain closed till 48 hours after the announcement of unaudited financial results for the quarter ended on 30th September, 2024. Kindly take on the records.

pdf